Mangoceuticals, Inc. (NASDAQ: MGRX) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 22.31% on the day to $2.96 following its close of a $5 million IPO.
Mangoceuticals, Inc. is a company focused on developing, marketing and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. To date, the company has identified men’s wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED).
The company’s common stock began trading on the Nasdaq Capital Market on March 21, 2023. So far today, approximately 98.24k shares of Mangoceuticals, Inc. have been exchanged.
To learn more about Mangoceuticals, Inc., visit the company’s website at https://www.mangorx.com.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN
IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer